Incidence and prevalence of cryptogenic fibrosing alveolitis in a Norwegian community.

This study assesses the incidence and prevalence of cryptogenic fibrosing alveolitis (CFA) in a well-defined and stable Norwegian population of 250,000 inhabitants during a period of 15 years. We conducted a file survey of all patients (n = 376) aged 16 years or older with a clinician's diagnosis of pulmonary fibrosis (ICD 8: 517 and ICD 9: 515 and 516). Cases with a history of exposure to fibrogenic agents or with collagen vascular disease were excluded and the remaining 158 cases were defined as CFA. The average annual incidence of hospitalised CFA was 4.3 per 100,000. No change was observed in the annual incidence during the 15-year study period. The prevalence was 19.7 and 23.9 per 100,000 by 31.12. 1991 and by 31.12. 1998, respectively. The incidence increased considerably and significantly with age. No significant gender differences were observed. The lack of gender differences and the increase with age were also found when the diagnosis of CFA was exclusively based on cases with hospital file records of breathlessness, bilateral crackles and bilateral shadows on chest radiograph.

[1]  T. Laitinen,et al.  Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland , 2002, Thorax.

[2]  R. Hubbard,et al.  Interstitial lung diseases: an epidemiological overview. , 2001, The European respiratory journal. Supplement.

[3]  R. D. du Bois,et al.  Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis. , 2001, The European respiratory journal. Supplement.

[4]  P. Cullinan,et al.  Clusters, classification and epidemiology of interstitial lung diseases: concepts, methods and critical reflections. , 2001, The European respiratory journal. Supplement.

[5]  T. Hartman,et al.  Smoking-related interstitial lung diseases: a concise review. , 2001, The European respiratory journal.

[6]  A. Gulsvik,et al.  Cigarette smoking gives more respiratory symptoms among women than among men The Nord-Trøndelag Health Study (HUNT) , 2000, Journal of epidemiology and community health.

[7]  R. Hubbard,et al.  Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. , 2000, American journal of respiratory and critical care medicine.

[8]  David A. Lynch,et al.  Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement , 2000 .

[9]  J A Waldron,et al.  Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. , 1997, American journal of respiratory and critical care medicine.

[10]  T. Duffy.  Access 97 , 1997 .

[11]  I. D. Johnston,et al.  British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society. , 1997, Thorax.

[12]  H. Schweisfurth.  [Report by the Scientific Working Group for Therapy of Lung Diseases: German Fibrosis Register with initial results]. , 1996, Pneumologie.

[13]  D. Coultas,et al.  Accuracy of mortality data for interstitial lung diseases in New Mexico, USA. , 1996, Thorax.

[14]  R. Hubbard,et al.  Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis , 1996, The Lancet.

[15]  W. Black,et al.  The epidemiology of interstitial lung diseases. , 1994, American journal of respiratory and critical care medicine.

[16]  V. Kolek.  Epidemiology of cryptogenic fibrosing alveolitis in Moravia and Silesia. , 1994, Acta Universitatis Palackianae Olomucensis Facultatis Medicae.

[17]  I. D. Johnston,et al.  The management of cryptogenic fibrosing alveolitis in three regions of the United Kingdom. , 1993, The European respiratory journal.

[18]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[19]  P. O'Byrne,et al.  Is nedocromil sodium effective treatment for asthma? , 1993, The European respiratory journal.

[20]  A. Gulsvik,et al.  Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents. , 1991, Thorax.

[21]  Douglas G. Altman,et al.  Practical statistics for medical research , 1990 .

[22]  I. D. Johnston,et al.  Rising mortality from cryptogenic fibrosing alveolitis. , 1990, BMJ.

[23]  I. D. Johnston,et al.  What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust. , 1990, BMJ.

[24]  B. Burrows,et al.  Cryptogenic fibrosing alveolitis: clinical features and their influence on survival , 1980, Thorax.

[25]  T. McLoud,et al.  Normal chest roentgenograms in chronic diffuse infiltrative lung disease. , 1978, The New England journal of medicine.

[26]  C. Carrington,et al.  Crackles (rales) in the interstitial pulmonary diseases. , 1978, Chest.